Medical Design Technology

News

Subscribe to MDT Magazine News

Medical device lobby spent $385K on lobbying in 1Q

June 21, 2010 10:45 am | by The Associated Press | Comments

The medical device industry's chief advocacy group spent more than $385,000 lobbying Congress in the first three months of 2010, as lawmakers finalized the health care overhaul.The group lobbied on the health care bill passed into law in March, which calls on medical device makers to pay...

NTU ramps up collaboration with Israel's top university

June 21, 2010 10:37 am | by EurekAlert | Comments

(Nanyang Technological University) Singapore's leading science and technology university, NTU and Israel's number one university, Technion-Israel Institute of Technology, announced a new collaboration to jointly offer a Doctor of Philosophy program and to increase the level of...

TOPICS:

Stryker Declares a $0.15 Per Share Quarterly Dividend

June 21, 2010 10:36 am | by Bio-Medicine.Org | Comments

KALAMAZOO, Mich. , June 21 /- Stryker Corporation (NYSE: SYK ) announced today that its Board of Directors has declared a quarterly dividend of $0.15 per share payable on July 30, 2010 to shareholders of record at the close of business on June 30, 2010 .     Stryker is one of...

TOPICS:
Advertisement

Former Medtronic executive gets top spot at Colorado spine firm

June 21, 2010 10:36 am | by Mass Device | Comments

Medtronic Inc.'s former chief operating officer Michael DeMane joins spinal surgery device company Lanx Inc. as chairman and CEO. By Thomas Lee Michael DeMane joined Lanx Inc. as chairman and CEO. The former chief operating officer at Medtronic Inc. (NYSE:MDT) was once...

TOPICS:

HeartSine Technologies Recognized as an Index 30 Company at New York-New Belfast Conference

June 21, 2010 10:35 am | by Bio-Medicine.Org | Comments

MINNEAPOLIS , June 21 /- HeartSine Technologies Ltd. recently joined 29 other companies on the 2010 Index 30, an annually compiled list of the most exciting companies with operations in the U.S. and Ireland . Other companies on this year's Index 30 list, compiled by The Irish Echo , the...

TOPICS:

Vigil Health Q4 loss balloons as revenue drops

June 21, 2010 9:45 am | by The Associated Press | Comments

Vigil Health Solutions Inc. saw its fourth-quarter and year-end losses balloon, hit by a drop in revenues for both periods.The company (TSXV:VGN), which provides emergency call and nurse call systems for seniors, said Monday its loss for the quarter ended March 31 increased to $235,782 from a...

Public Hearing: Development of Articles for Rare Diseases, June 29-30, 2010

June 21, 2010 9:35 am | by U.S. Food & Drug Administration | Comments

This public hearing is intended to gain from health care providers, academia, industry, patients, and other interested persons their perspectives on various aspects of the development of medical products for the diagnosis, treatment, or management of...

How to become a salesperson of influence

June 21, 2010 9:35 am | by Mass Device | Comments

Ten tips to help medical device salespeople become influential advisors to their hospital and physician customers. The other day I spoke to a sales trainer, who was a reference for a candidate. He talked about the difference between being a "pleaser" and an "adviser" to customers. The...

TOPICS:
Advertisement

MedGadget's MedTech Monday: Custom-fit degradable cranial implant

June 21, 2010 8:35 am | by Mass Device | Comments

A custom-fit degradable implant for filling bone defects after craniofacial surgery; a study shows Bard's LifeStent as superior to stentless angioplasty; Micrus' DeltaPAQ and DeltaPlush microcoils cleared in Japan; and CorMatrix's cardiac tissue repair wins CE Mark. ...

TOPICS:

EarlySense wins FDA clearance for patient monitoring system

June 21, 2010 8:35 am | by Mass Device | Comments

Israeli-based medical device company EarlySense Ltd. receives U.S. Food & Drug Administration approval to sell its EverOn Touch patient monitoring system in the United States. By Mary Vanac Ramat Gan, Israel-based medical device company EarlySense Ltd., which recently...

TOPICS:

Docs increasingly abandon Medicare

June 21, 2010 7:36 am | by Mass Device | Comments

More and more physicians are cutting Medicare patients from their rosters after Congress fails to stay a 21 percent reimbursement rate cut. As Congress allowed a 21 percent reduction in reimbursement rates for doctors to come into effect, the number of physicians pulling out of...

TOPICS:

Encouraging results from the largest clinical study ever conducted on treating depression with Omega-3

June 21, 2010 6:38 am | by EurekAlert | Comments

(Centre hospitalier de l'Université de Montréal) The use of Omega-3 supplements is effective among patients with major depression who do not have anxiety disorders, according to a study directed by Dr. Francois Lesperance of the Centre de recherche du Centre hospitalier at the...

TOPICS:

FDA to expedite ev3's Pipeline

June 21, 2010 6:37 am | by Mass Device | Comments

The Food & Drug Administration grants ev3 Inc. an expedited review of the pre-market approval application the company filed in May for its Pipeline cerebral aneurysm treatment. One of Covidien plc's (NYSE:COV) pending acquisitions won some good news from the Food & Drug...

TOPICS:

Covidien registers for debt sale to cover $2.3 billion ev3 buyout

June 21, 2010 6:36 am | by Mass Device | Comments

Covidien plc registers for an offering of an undisclosed amount of debt, aimed at raising cash to help pay for its $2.3 billion buyout of ev3 Inc. Covidien plc (NYSE:COV) registered for a debt offering with the Securities & Exchange Commission, aiming to drum up some cash...

TOPICS:

Sinapis Pharma Commences Phase I Trial

June 21, 2010 6:36 am | by Bio-Medicine.Org | Comments

JACKSONVILLE, Fla. , June 21 /- Sinapis Pharma, Inc. announces that its first patients were dosed in a Phase I clinical trial study on June 14, 2010 . This study, in human volunteers, is designed to evaluate the safety, pharmacokinetics, and absolute bioavailability of an intravenous...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading